NCT01392963View on ClinicalTrials.gov

The Treatment of Depression With Botulinum Type A Toxin

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

June 30, 2013

Conditions
Depression
Interventions
DRUG

botulinum toxin type A neurotoxin complex

29-40 U injection

DRUG

Placebo

29-40 U 0.9% NaCl injection

Trial Locations (1)

78705

Seton Mind Institute: Medical Park Tower, Austin

All Listed Sponsors
lead

Seton Healthcare Family

OTHER

NCT01392963 - The Treatment of Depression With Botulinum Type A Toxin | Biotech Hunter | Biotech Hunter